Biocon
BSE: 532523 | NSE: BIOCON | ISIN: INE376G01013 | SECTOR: Biotechnology & DrugsRatios
- Management Effectiveness
- Margins
- Financial Strength
- Valuation
- Income Statement
- Growth
- Per Share Data
- Price and Volume
Return on average equity - 5 year average
8.75Net Income/employee - trailing 12 month
43,70,305.00Revenue/employee - most recent fiscal year
3,38,04,870.00Return on investment - most recent fiscal year
2.36Return on average assets - most recent fiscal year
1.78Receivables turnover - most recent fiscal year
3.89Return on investment - trailing 12 month
-Return on average assets - trailing 12 month
-Inventory turnover - most recent fiscal year
1.28Inventory turnover - trailing 12 month
-Revenue/employee - trailing 12 month
4,28,77,050.00Return on average assets - 5 year average
4.31Net Income/employee - most recent fiscal year
19,45,243.00Return on average equity - trailing 12 month
-Receivables turnover - trailing 12 month
-Asset turnover - most recent fiscal year
0.31Asset turnover - trailing 12 month
-Return on average equity - most recent fiscal year
3.52Return on investment - 5 year average
5.91